Cardiovascular outcomes trials for glucose-lowering therapies : what do the results mean for practice?
Newland-Jones, Phillip
Newland-Jones, Phillip
Citations
Altmetric:
Affiliation
University of Southampton; University of Warwick; George Eliot Hospital NHS Trust, Nuneaton
Other Contributors
Publication date
2015-12-15
Subject
Collections
Research Projects
Organizational Units
Journal Issue
Abstract
DigestDEBATE: In this section, a panel of multidisciplinary team members give their opinions on a recently published paper. In this issue, we discuss the outcome of the cardiovascular safety trial of empagliflozin, and what the results mean for clinical practice in the UK.
Citation
Newland-Jones P, Patel V. Cardiovascular outcomes trials for glucose-lowering therapies: What do the results mean for practice? Diabetes Digest. 2015 December;14(4):191-192.
Type
Article